IMP
Process View
positive regulation of interferon gamma mediated signaling pathway
Any process that increases the rate, frequency or extent of the series of molecular events generated as a consequence of interferon-gamma binding to a cell surface receptor.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of interferon gamma mediated signaling pathway"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| SYK | spleen tyrosine kinase | 0.973 | ||
| MED28 | mediator complex subunit 28 | 0.819 | ||
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.816 | Human | |
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.721 | ||
| BLNK | B-cell linker | 0.684 | ||
| LCK | lymphocyte-specific protein tyrosine kinase | 0.568 | Human | |
| GRB2 | growth factor receptor-bound protein 2 | 0.550 | ||
| CDK8 | cyclin-dependent kinase 8 | 0.528 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.505 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.481 | ||
| HCK | hemopoietic cell kinase | 0.475 | Human | |
| SPRR2A | small proline-rich protein 2A | 0.236 | ||
| LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.213 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.192 | ||
| PIK3R3 | phosphoinositide-3-kinase, regulatory subunit 3 (gamma) | 0.177 | ||
| VAV1 | vav 1 guanine nucleotide exchange factor | 0.152 | ||
| SH3KBP1 | SH3-domain kinase binding protein 1 | 0.151 | ||
| ITK | IL2-inducible T-cell kinase | 0.131 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.117 | ||
| IBTK | inhibitor of Bruton agammaglobulinemia tyrosine kinase | 0.113 | ||
| PIK3R2 | phosphoinositide-3-kinase, regulatory subunit 2 (beta) | 0.100 | ||
| GRB7 | growth factor receptor-bound protein 7 | 0.098 | ||
| NCK1 | NCK adaptor protein 1 | 0.095 | ||
| RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.085 | ||
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.077 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.075 | ||
| CD2AP | CD2-associated protein | 0.075 | ||
| EGFR | epidermal growth factor receptor | 0.068 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.065 | ||
| UBASH3B | ubiquitin associated and SH3 domain containing B | 0.060 | ||
| WIPF1 | WAS/WASL interacting protein family, member 1 | 0.055 | ||
| TNS3 | tensin 3 | 0.046 | ||
| WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.043 | ||
| MDM4 | Mdm4 p53 binding protein homolog (mouse) | 0.041 | ||
| CD3E | CD3e molecule, epsilon (CD3-TCR complex) | 0.035 | ||
| DOK1 | docking protein 1, 62kDa (downstream of tyrosine kinase 1) | 0.034 | ||
| PRKCB | protein kinase C, beta | 0.033 | ||
| IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.032 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.032 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.030 | Human | |
| PYCARD | PYD and CARD domain containing | 0.030 | ||
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.030 | ||
| VAV2 | vav 2 guanine nucleotide exchange factor | 0.029 | ||
| PLCG2 | phospholipase C, gamma 2 (phosphatidylinositol-specific) | 0.029 | ||
| PRKCQ | protein kinase C, theta | 0.028 | ||
| ZAP70 | zeta-chain (TCR) associated protein kinase 70kDa | 0.025 | ||
| FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 0.025 | Human | |
| PDCD6IP | programmed cell death 6 interacting protein | 0.023 | ||
| TNPO1 | transportin 1 | 0.022 | ||
| THRAP3 | thyroid hormone receptor associated protein 3 | 0.022 | ||
| TNS4 | tensin 4 | 0.022 | ||
| FCGR2A | Fc fragment of IgG, low affinity IIa, receptor (CD32) | 0.021 | ||
| DLG4 | discs, large homolog 4 (Drosophila) | 0.019 | ||
| PSTPIP1 | proline-serine-threonine phosphatase interacting protein 1 | 0.019 | ||
| STAP2 | signal transducing adaptor family member 2 | 0.018 | ||
| ARID3A | AT rich interactive domain 3A (BRIGHT-like) | 0.017 | ||
| CD79A | CD79a molecule, immunoglobulin-associated alpha | 0.017 | ||
| SHC3 | SHC (Src homology 2 domain containing) transforming protein 3 | 0.016 | ||
| MED10 | mediator complex subunit 10 | 0.016 | ||
| ANG | angiogenin, ribonuclease, RNase A family, 5 | 0.016 | ||
| FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide | 0.016 | ||
| SH3BP2 | SH3-domain binding protein 2 | 0.016 | ||
| SH3BP5 | SH3-domain binding protein 5 (BTK-associated) | 0.016 | ||
| GBP5 | guanylate binding protein 5 | 0.015 | ||
| NRG1 | neuregulin 1 | 0.015 | ||
| VAV3 | vav 3 guanine nucleotide exchange factor | 0.014 | ||
| MED29 | mediator complex subunit 29 | 0.014 | ||
| TGS1 | trimethylguanosine synthase 1 | 0.014 | ||
| GTF2I | general transcription factor IIi | 0.013 | ||
| LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 0.013 | ||
| BTK | Bruton agammaglobulinemia tyrosine kinase | 0.013 | Human | |
| PDCD6 | programmed cell death 6 | 0.012 | ||
| ABL2 | v-abl Abelson murine leukemia viral oncogene homolog 2 | 0.012 | ||
| DAPP1 | dual adaptor of phosphotyrosine and 3-phosphoinositides | 0.011 | ||
| THRA | thyroid hormone receptor, alpha (erythroblastic leukemia viral (v-erb-a) oncogene homolog, avian) | 0.011 | ||
| MED26 | mediator complex subunit 26 | 0.010 | ||
| CISH | cytokine inducible SH2-containing protein | 0.010 | ||
| MUC1 | mucin 1, cell surface associated | 0.010 |